Analystreport

Ligand Pharmaceuticals Inc. (NASDAQ: LGND) had its price target raised by analysts at Argus to $300.00. They now have an "average" rating on the stock.

Ligand Pharmaceuticals Incorporated  (LGND) 
Last ligand pharmaceuticals incorporated earnings: 2/6 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.ligand.com